Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glutamine N-acyltransferase activity	GLYATL1 GLYATL1B	6.30e-05	2	159	2	GO:0047946
HumanPheno	Open mouth	LAMA2 PLXND1 DST SETBP1 CACNA1I DENND5A MBD5 VPS13B PUS7	2.03e-06	124	49	9	HP:0000194
HumanPheno	Abnormality of the chin	HSPG2 ERCC4 TRIO PTDSS1 TRIP12 DST SETBP1 SVIL ANKRD11 LRP4 MBD5 PLK4 PUS7 MAN1B1	1.84e-05	409	49	14	HP:0000306
HumanPheno	Sandal gap	TRIO TRIP12 SETBP1 SVIL MBD5 PLK4 VPS13B	3.05e-05	96	49	7	HP:0001852
HumanPheno	Elevated circulating aldolase concentration	HSPG2 DPYS OBSCN	6.75e-05	9	49	3	HP:0012544
HumanPheno	Abnormality of mouth shape	HSPG2 LAMA2 PLXND1 TRIP12 DST SETBP1 CACNA1I DENND5A MBD5 VPS13B PUS7	7.95e-05	294	49	11	HP:0011338
HumanPheno	Abnormal circulating aldolase concentration	HSPG2 DPYS OBSCN LARGE1	9.67e-05	26	49	4	HP:0012400
Domain	-	BOC HSPG2 TRIO SPEG CD300A OBSCN PLXND1 PTGFRN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 ERMAP CNTN3 COL14A1 ROS1 LY9 HCFC1 SORL1	1.15e-06	663	161	20	2.60.40.10
Domain	Ig-like_fold	BOC HSPG2 TRIO SPEG CD300A OBSCN PLXND1 PTGFRN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 ERMAP CNTN3 COL14A1 ROS1 LY9 HCFC1 SORL1	3.00e-06	706	161	20	IPR013783
Domain	IG	BOC HSPG2 TRIO SPEG CD300A OBSCN PTGFRN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 ERMAP CNTN3 LY9	3.79e-06	421	161	15	SM00409
Domain	Ig_sub	BOC HSPG2 TRIO SPEG CD300A OBSCN PTGFRN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 ERMAP CNTN3 LY9	3.79e-06	421	161	15	IPR003599
Domain	FN3	BOC SPEG OBSCN IGDCC4 IGSF22 CNTN3 COL14A1 ROS1 HCFC1 SORL1	4.75e-06	185	161	10	SM00060
Domain	Ig_I-set	BOC HSPG2 TRIO SPEG OBSCN IGDCC4 IGSF10 IGSF22 CD22 CNTN3	6.02e-06	190	161	10	IPR013098
Domain	I-set	BOC HSPG2 TRIO SPEG OBSCN IGDCC4 IGSF10 IGSF22 CD22 CNTN3	6.02e-06	190	161	10	PF07679
Domain	IGc2	BOC HSPG2 TRIO SPEG OBSCN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 CNTN3	6.30e-06	235	161	11	SM00408
Domain	Ig_sub2	BOC HSPG2 TRIO SPEG OBSCN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 CNTN3	6.30e-06	235	161	11	IPR003598
Domain	FN3	BOC SPEG OBSCN IGDCC4 IGSF22 CNTN3 COL14A1 ROS1 HCFC1 SORL1	9.05e-06	199	161	10	PS50853
Domain	fn3	BOC SPEG OBSCN IGDCC4 IGSF22 CNTN3 COL14A1 ROS1 SORL1	1.15e-05	162	161	9	PF00041
Domain	FN3_dom	BOC SPEG OBSCN IGDCC4 IGSF22 CNTN3 COL14A1 ROS1 HCFC1 SORL1	1.39e-05	209	161	10	IPR003961
Domain	IG_LIKE	BOC HSPG2 TRIO SPEG CD300A OBSCN PTGFRN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 ERMAP CNTN3 LY9	2.35e-05	491	161	15	PS50835
Domain	Ig-like_dom	BOC HSPG2 TRIO SPEG CD300A OBSCN PTGFRN IGDCC4 IGSF10 IGSF22 CD22 IL1R2 ERMAP CNTN3 LY9	3.11e-05	503	161	15	IPR007110
Domain	Cell_morpho_N	FRYL FRY	7.39e-05	2	161	2	IPR025614
Domain	Cell_Morphogen_C	FRYL FRY	7.39e-05	2	161	2	IPR025481
Domain	MOR2-PAG1_mid	FRYL FRY	7.39e-05	2	161	2	IPR029473
Domain	MOR2-PAG1_mid	FRYL FRY	7.39e-05	2	161	2	PF14228
Domain	MOR2-PAG1_C	FRYL FRY	7.39e-05	2	161	2	PF14225
Domain	MOR2-PAG1_N	FRYL FRY	7.39e-05	2	161	2	PF14222
Domain	LY	LRP4 ROS1 SORL1	2.65e-04	15	161	3	SM00135
Domain	LDLR_classB_rpt	LRP4 ROS1 SORL1	2.65e-04	15	161	3	IPR000033
Domain	Ig_V-set	BOC HSPG2 CD300A OBSCN PTGFRN IGSF10 ERMAP CNTN3	3.37e-04	199	161	8	IPR013106
Domain	GDS_CDC24_CS	TRIO OBSCN ARHGEF11 FARP2	3.46e-04	39	161	4	IPR001331
Domain	IGv	HSPG2 OBSCN PTGFRN IGSF10 ERMAP	4.75e-04	75	161	5	SM00406
Domain	ig	BOC HSPG2 OBSCN PTGFRN CD22 IL1R2 CNTN3	1.32e-03	190	161	7	PF00047
Domain	Immunoglobulin	BOC HSPG2 OBSCN PTGFRN CD22 IL1R2 CNTN3	1.32e-03	190	161	7	IPR013151
Domain	P_proprotein	PCSK7 PCSK4	1.51e-03	7	161	2	PF01483
Domain	S8_pro-domain	PCSK7 PCSK4	1.51e-03	7	161	2	IPR032815
Domain	PrprotnconvertsP	PCSK7 PCSK4	1.51e-03	7	161	2	IPR002884
Domain	-	PCSK7 PCSK4	1.51e-03	7	161	2	3.30.70.850
Domain	S8_pro-domain	PCSK7 PCSK4	1.51e-03	7	161	2	PF16470
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6B USP34 HSPG2 ABCA2 TRIO MYO7A SPEG OBSCN FRYL PLXND1 ANKHD1 ARHGEF11 WDR59 C8orf58 DST WIZ RRP12 ANKRD11 LRP4 COBL DENND5A SNAPC4 MBD5 SMURF2 HCFC1 MED13 PKN3 SMG6	4.53e-13	1105	165	28	35748872
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	BOC TRIO SPEG CD300A OBSCN PTGFRN IGDCC4 IGSF10 CD22 CNTN3 LY9	3.77e-10	162	165	11	25826454
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ANK3 MAP2 MYO7A SPEG OBSCN TOGARAM2 CDK11A SPG11 PRPF6 ARHGEF11 TRIP12 RRP12 ANKRD11 COBL GAN HCFC1	2.30e-09	497	165	16	36774506
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ABCA2 PLXND1 ARHGEF11 TRIP12 DST RRP12 LRP4 MBD5 MED13	1.32e-08	130	165	9	12421765
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF13B STARD8 SYNM KDM4C PTDSS1 PTGFRN WDR59 FARP2 LTN1 ARHGAP25 MINAR1 TMEM41B MBD5 PUS7 UTP14C	1.58e-08	493	165	15	15368895
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B TRIO MAP2 CCDC85C FRYL SSRP1 TRIP12 WDR59 GAB2 LATS1 DST DENND1B YAP1 SVIL ANKRD11 RAB11FIP5 COBL GAN PLK4	3.18e-08	861	165	19	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 ABCA2 SPG11 PLXND1 ANKHD1 SF3B3 DST SETBP1 CAPRIN2 LRP4 RAB11FIP5 RIMS2 MED13 SMG6	2.65e-07	529	165	14	14621295
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYLC1 GARIN5B KIF13B WDR33 ACO2 LAMP5 SPG11 PRPF6 SSRP1 TRIP12 LATS1 SF3B3 DST KHDRBS3 GCLC CAPRIN2 UGGT2 ALAS2 RIMS2 MTDH SMURF2 MED13 UTP14C	3.73e-07	1442	165	23	35575683
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	USP34 KDM4C FARP2 DST LTN1 RIMS2 SMG6	5.63e-07	101	165	7	9872452
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	USP34 HSPG2 ABCA2 B4GALNT1 PTDSS1 DCBLD1 PLXND1 PTGFRN IGSF10 TXNDC5 RRP12 SVIL LTN1 LRP4 UGGT2 TMEM41B MTDH PBXIP1 MAN1B1 SORL1	1.20e-06	1201	165	20	35696571
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	WDR33 USP11 FARP2 ATP6V1H SVIL LTN1 RAB11FIP5 HCFC1 PBXIP1 PKN3	2.76e-06	313	165	10	38270169
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 ERBB3 ABCA2 ANK3 TRIO SYNM KDM4C USP11 SEC31B TRIP12 WDR59 NUFIP1 FRY DST FBH1 WIZ LRP4 SMURF2 PBXIP1 MED13	3.32e-06	1285	165	20	35914814
Pubmed	Deficiency of large tumor suppressor kinase 1 causes congenital hearing loss associated with cochlear abnormalities in mice.	MYO7A LATS1 YAP1	3.62e-06	7	165	3	33162027
Pubmed	Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal.	MYO7A LATS1 YAP1	3.62e-06	7	165	3	32482884
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KIF13B ANK3 MYO7A EML4 PTDSS1 CCDC85C CDK11A PRPF6 SSRP1 GAB2 SF3B3 TXNDC5 YAP1 GAN UGGT2 COL14A1 TMEM41B PKN3 SORL1 LARGE1	5.01e-06	1321	165	20	27173435
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ANK3 TRIO MAP2 PTDSS1 OBSCN CCDC85C FRYL ZHX2 FARP2 FBXO16 DENND1B TBC1D22A SETBP1 ANKRD11 COBL DENND5A MBD5 SMURF2 VPS13B MAN1B1 SMG6	8.45e-06	1489	165	21	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PTDSS1 CDK11A BUD13 SSRP1 ZHX2 ANKHD1 ARHGEF11 DDX10 FARP2 DST WIZ EXD2 RRP12 LTN1 ANKRD11 PPP1R18 PBXIP1 MED13 MAN1B1 SEC13 SMG6	9.16e-06	1497	165	21	31527615
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	USP34 LZTS3 GAB2 MED13 VPS13B LARGE1	1.14e-05	105	165	6	9628581
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KIF13B USP34 ERCC4 STARD8 TRH ANK3 OBSCN FRYL ZNF101 ANKHD1 TRIP12 LTN1 LPAR2 MTDH VPS13B MAN1B1 UTP14C	1.72e-05	1084	165	17	11544199
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 AFF2 ANK3 SYNM PLXND1 TRIP12 GAB2 DST WIZ EXD2 RAB11FIP5 MTDH SEC23A SEC13	2.22e-05	777	165	14	35844135
Pubmed	NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.	LATS1 YAP1 SMURF2	2.24e-05	12	165	3	24107629
Pubmed	Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.	FOXM1 YAP1	2.24e-05	2	165	2	28249813
Pubmed	The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival.	LATS1 YAP1	2.24e-05	2	165	2	29850494
Pubmed	ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.	ANKHD1 YAP1	2.24e-05	2	165	2	24726915
Pubmed	Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.	LATS1 YAP1	2.24e-05	2	165	2	25625370
Pubmed	SNP rs9387478 at ROS1-DCBLD1 Locus is Significantly Associated with Lung Cancer Risk and Poor Survival in Indian Population.	DCBLD1 ROS1	2.24e-05	2	165	2	36308382
Pubmed	Methylation‑associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma.	LATS1 YAP1	2.24e-05	2	165	2	25270913
Pubmed	YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression.	ERBB3 YAP1	2.24e-05	2	165	2	25798835
Pubmed	Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.	LATS1 YAP1	2.24e-05	2	165	2	25772246
Pubmed	ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.	ANKHD1 YAP1	2.24e-05	2	165	2	32319569
Pubmed	Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.	LATS1 YAP1	2.24e-05	2	165	2	32238586
Pubmed	Characterization of ATPase in sarcoplasmic reticulum from two strains of dystrophic mice.	LAMA2 LARGE1	2.24e-05	2	165	2	6447833
Pubmed	Molecular regulation of trophoblast stem cell self-renewal and giant cell differentiation by the Hippo components YAP and LATS1.	LATS1 YAP1	2.24e-05	2	165	2	35526072
Pubmed	Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases.	SPEG OBSCN	2.24e-05	2	165	2	15185077
Pubmed	Naked axons in myodystrophic mice.	LAMA2 LARGE1	2.24e-05	2	165	2	647395
Pubmed	LATS1 Promotes B-ALL Tumorigenesis by Regulating YAP1 Phosphorylation and Subcellular Localization.	LATS1 YAP1	2.24e-05	2	165	2	38277019
Pubmed	Dual Role of a C-Terminally Truncated Isoform of Large Tumor Suppressor Kinase 1 in the Regulation of Hippo Signaling and Tissue Growth.	LATS1 YAP1	2.24e-05	2	165	2	30461308
Pubmed	The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.	LATS1 YAP1	2.24e-05	2	165	2	25393475
Pubmed	Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.	LATS1 YAP1	2.24e-05	2	165	2	28504812
Pubmed	Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.	LATS1 YAP1	2.24e-05	2	165	2	26921249
Pubmed	FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.	FOXM1 YAP1	2.24e-05	2	165	2	26299613
Pubmed	Cadmium promotes the binding and centrosomal translocation of CCDC85C and PLK4 via ROS-GCLM pathway to trigger centrosome amplification in colon cancer cells.	CCDC85C PLK4	2.24e-05	2	165	2	38185225
Pubmed	Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.	LATS1 YAP1	2.24e-05	2	165	2	24682895
Pubmed	Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.	FOXM1 MTDH	2.24e-05	2	165	2	27923917
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	DPYS LAMA2 ZNF112 RIMS2 PBXIP1	2.29e-05	71	165	5	33541421
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXM1 KIF13B USP34 CWF19L2 WDR33 USP11 CDK11A SF3B3 IQCC YAP1 RAB11FIP5 SORL1	2.64e-05	588	165	12	38580884
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANK3 MAP2 SYNM USP11 PTDSS1 SPG11 PRPF6 SSRP1 DDX10 SF3B3 TXNDC5 RRP12 ANKRD11 RAB11FIP5 UGGT2 COL14A1 MTDH PBXIP1 VPS13B PUS7	2.77e-05	1487	165	20	33957083
Pubmed	Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.	KDM4C PLEKHF2 PLK4	4.58e-05	15	165	3	20923822
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CWF19L2 WDR33 EML4 CDK11A BUD13 PRPF6 SSRP1 TRIP12 DDX10 SF3B3 WIZ ANKRD11 ZCCHC7 MTDH HCFC1	5.35e-05	954	165	15	36373674
Pubmed	No replication of genetic association between candidate polymorphisms and Alzheimer's disease.	HSPG2 PLAU SORL1	5.61e-05	16	165	3	19889475
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CWF19L2 MAP2 WDR33 ACO2 PTDSS1 BUD13 PRPF6 SSRP1 TRIP12 SF3B3 DST WIZ KHDRBS3 RRP12 MTDH PBXIP1	6.18e-05	1082	165	16	38697112
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CDK11A SSRP1 TRIP12 DDX10 WIZ DENND5A MTDH HCFC1	6.63e-05	283	165	8	30585729
Pubmed	Myosin VIIA is specifically associated with calmodulin and microtubule-associated protein-2B (MAP-2B).	MAP2 MYO7A	6.69e-05	3	165	2	11171103
Pubmed	Downregulation of circ_PLXND1 inhibits tumorigenesis of non-small cell lung carcinoma via miR-1287-5p/ERBB3 axis.	ERBB3 PLXND1	6.69e-05	3	165	2	37073425
Pubmed	HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.	LATS1 YAP1	6.69e-05	3	165	2	39248565
Pubmed	miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.	YAP1 SEC23A	6.69e-05	3	165	2	27832783
Pubmed	RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.	LATS1 YAP1	6.69e-05	3	165	2	27325643
Pubmed	Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.	GAB2 SORL1	6.69e-05	3	165	2	20634593
Pubmed	PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling.	LATS1 YAP1	6.69e-05	3	165	2	32645410
Pubmed	Plau and Tgfbr3 are YAP-regulated genes that promote keratinocyte proliferation.	YAP1 PLAU	6.69e-05	3	165	2	30382077
Pubmed	The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling.	ANKHD1 YAP1	6.69e-05	3	165	2	35110552
Pubmed	Mammalian homologues of yeast sec31p. An ubiquitously expressed form is localized to endoplasmic reticulum (ER) exit sites and is essential for ER-Golgi transport.	SEC31B SEC13	6.69e-05	3	165	2	10788476
Pubmed	Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl.	MAP2 COBL	6.69e-05	3	165	2	29689199
Pubmed	Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.	HSPG2 LARGE1	6.69e-05	3	165	2	16098969
Pubmed	FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells.	FOXM1 PLAU	6.69e-05	3	165	2	25962429
Pubmed	Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway.	LAMA2 YAP1	6.69e-05	3	165	2	27435623
Pubmed	LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.	LATS1 YAP1	6.69e-05	3	165	2	38754347
Pubmed	Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].	LATS1 YAP1	6.69e-05	3	165	2	21383157
Pubmed	Genetic variants and clinical relevance associated with gestational diabetes mellitus in Chinese women: a case-control study.	PLXND1 ARHGEF11	6.69e-05	3	165	2	28554271
Pubmed	The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity.	LGALS9 ERMAP	6.69e-05	3	165	2	37813965
Pubmed	YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.	LATS1 YAP1	6.69e-05	3	165	2	29903769
Pubmed	HTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis.	LATS1 YAP1	6.69e-05	3	165	2	35210364
Pubmed	A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance.	ERBB3 SORL1	6.69e-05	3	165	2	33420373
Pubmed	YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.	GAB2 YAP1	6.69e-05	3	165	2	28202507
Pubmed	Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.	GAB2 SORL1	6.69e-05	3	165	2	26611835
Pubmed	Regulation of YAP by mechanical strain through Jnk and Hippo signaling.	LATS1 YAP1	6.69e-05	3	165	2	25127217
Pubmed	Crosstalk between Hippo signalling and miRNAs in tumour progression.	LATS1 YAP1	6.69e-05	3	165	2	27973704
Pubmed	Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.	LATS1 YAP1	6.69e-05	3	165	2	18413746
Pubmed	Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation.	GAB2 GAB3	6.69e-05	3	165	2	30936879
Pubmed	Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway.	FOXM1 YAP1	6.69e-05	3	165	2	36620877
Pubmed	Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.	GAB2 GAB3	6.69e-05	3	165	2	11997510
Pubmed	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.	EML4 ROS1	6.69e-05	3	165	2	30107055
Pubmed	Tumor suppressor LATS1 is a negative regulator of oncogene YAP.	LATS1 YAP1	6.69e-05	3	165	2	18158288
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERBB3 ERCC4 EML4 ANKHD1 FARP2 DST UGGT2 DENND5A HCFC1 PBXIP1 MAN1B1 SORL1	6.91e-05	650	165	12	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 USP11 FRYL PRPF6 ANKHD1 TRIP12 DDX10 DST RRP12 HCFC1 SEC23A SEC13	7.22e-05	653	165	12	22586326
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	USP34 TRIO CCDC85C TRIP12 DST GCLC LTN1	7.29e-05	212	165	7	33853758
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 IL16 DCDC1 USP11 BUD13 ZKSCAN2 SSRP1 ANKHD1 NUFIP1 SF3B3 WIZ CAPRIN2 LTN1 LRP4 RAB11FIP5 SORL1	8.85e-05	1116	165	16	31753913
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FOXM1 EML4 CDK11A BUD13 SSRP1 TRIP12 LATS1 YAP1 RRP12 SVIL PPP1R18 SNAPC4 MED13	8.91e-05	774	165	13	15302935
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	CWF19L2 ERCC4 CDK11A PRPF6 WIZ HCFC1 SEC23A	9.72e-05	222	165	7	37071664
Pubmed	The ULK1-FBXW5-SEC23B nexus controls autophagy.	FBXO16 FBH1 SEC13	1.13e-04	20	165	3	30596474
Pubmed	Structural basis for cargo regulation of COPII coat assembly.	SEC23A SEC13	1.33e-04	4	165	2	18692470
Pubmed	Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.	LATS1 YAP1	1.33e-04	4	165	2	28754671
Pubmed	Vinculin promotes nuclear localization of TAZ to inhibit ECM stiffness-dependent differentiation into adipocytes.	LATS1 YAP1	1.33e-04	4	165	2	28115535
Pubmed	A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.	ERBB3 YAP1	1.33e-04	4	165	2	28114269
Pubmed	Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.	LATS1 YAP1	1.33e-04	4	165	2	21041411
Pubmed	Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.	LATS1 YAP1	1.33e-04	4	165	2	20841485
Pubmed	Hippo signaling instructs ectopic but not normal organ growth.	LATS1 YAP1	1.33e-04	4	165	2	36395225
Pubmed	Molecular recognition by LARGE is essential for expression of functional dystroglycan.	LAMA2 LARGE1	1.33e-04	4	165	2	15210115
Pubmed	Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype.	GAB2 SORL1	1.33e-04	4	165	2	23525328
Pubmed	SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.	LATS1 YAP1	1.33e-04	4	165	2	27847303
Interaction	TOP3B interactions	SEMA6B USP34 HSPG2 ABCA2 TRIO MYO7A SPEG OBSCN FRYL PLXND1 SSRP1 ANKHD1 ARHGEF11 WDR59 C8orf58 DST WIZ RRP12 SVIL ANKRD11 LRP4 COBL DENND5A SNAPC4 MBD5 SMURF2 HCFC1 MED13 SEC23A PKN3 SMG6	5.45e-07	1470	161	31	int:TOP3B
Interaction	FBXO22 interactions	ANK3 MAP2 MYO7A KDM4C SPEG OBSCN TOGARAM2 CDK11A SPG11 PRPF6 ARHGEF11 TRIP12 RRP12 ANKRD11 COBL GAN HCFC1	1.61e-06	540	161	17	int:FBXO22
Cytoband	Ensembl 112 genes in cytogenetic band chr8q22	DPYS PLEKHF2 PTDSS1 BAALC-AS2 RIMS2 MTDH VPS13B	2.77e-06	168	165	7	chr8q22
Cytoband	17q22-q23	SMURF2 MED13	1.91e-04	6	165	2	17q22-q23
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	BOC HSPG2 TRIO SPEG OBSCN IGDCC4 IGSF10 IGSF22 CNTN3	4.79e-07	161	107	9	593
GeneFamily	Fibronectin type III domain containing	BOC OBSCN IGDCC4 IGSF22 CNTN3 COL14A1 ROS1 SORL1	4.90e-06	160	107	8	555
GeneFamily	Immunoglobulin like domain containing	BOC HSPG2 PTGFRN IGDCC4 IL1R2 CNTN3 LY9	1.50e-04	193	107	7	594
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO OBSCN ARHGEF11 FARP2	6.30e-04	66	107	4	722
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 MYO7A SYNM	6.58e-04	29	107	3	396
GeneFamily	Proprotein convertase subtilisin/kexin family	PCSK7 PCSK4	1.22e-03	9	107	2	973
Coexpression	GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP	IL16 ZNF101 DDX10 GCLC IL1R2 RRP12 TMEM41B HCFC1 SEC23A SEC13	5.35e-07	200	163	10	M9953
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL	BOC MAP2 SPEG LAMP5 ZHX2 LGALS9 DST KIAA1549L GCLC LRP4 PPP1R18 COL14A1 PLAU	8.10e-07	380	163	13	M45714
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 TRIO KDM4C SPG11 FRYL ZHX2 TRIP12 DDX10 ATP6V1H DST YAP1 LTN1 FGF5 DENND5A SMURF2 MED13 VPS13B	2.60e-05	856	163	17	M4500
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	USP34 PLXND1 SETBP1 COBL ARHGAP25 TMEM41B	3.27e-05	97	163	6	M14698
Coexpression	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN	IL16 ANK3 USP11 ZHX2 SEC31B CAPRIN2 LY9 MAN1B1	3.65e-05	199	163	8	M4620
Coexpression	GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	MYO7A C8orf58 IQCC EXD2 GAB3 SLC25A53 PCSK4 PUS7	3.65e-05	199	163	8	M7190
Coexpression	GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	BOC FOXN4 PLEKHF2 IRX1 PTGFRN CD22 PCSK7 ARHGAP25	3.78e-05	200	163	8	M9348
Coexpression	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN	ABCA2 WDR33 ZHX2 C8orf58 EXD2 GAB3 LY9 PCSK4	3.78e-05	200	163	8	M7197
Coexpression	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN	B4GALNT1 MYO7A USP11 CAPRIN2 GAB3 SLC25A53 PUS7 SORL1	3.78e-05	200	163	8	M7161
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP	FOXM1 IL16 ANK3 TRIO CD300A FRYL ANKHD1 WDR59 CD22 TMEM41B MTDH LARGE1	4.49e-05	475	163	12	M40979
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	BOC LZTS3 MAP2 GAB2 IGDCC4 DST TBC1D22A PLAU SNAPC4 PBXIP1	5.24e-05	337	163	10	M13206
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	KIF13B TRIO YAP1 SVIL UGGT2 RIMS2 VPS13B	9.37e-05	169	163	7	M39230
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	CWF19L2 WDR33 EML4 CDK11A FRYL NUFIP1 FBXO16 ATP6V1H DENND1B RRP12 TMEM41B PBXIP1 MED13 SORL1	9.48e-05	680	163	14	M41089
Coexpression	GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP	ANK3 CCDC85C FRYL IRX1 DDX10 DENND1B RWDD4	9.72e-05	170	163	7	M8130
Coexpression	QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE	CD300A ZHX2 TRIP12 GAB2 GAB3 ARHGAP25 LPAR2 DENND5A HCFC1	9.86e-05	294	163	9	M40873
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 CWF19L2 ANK3 EML4 CDK11A FRYL ANKRD11 PCSK7 VPS13B SMG6	3.93e-09	199	165	10	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TRIO TBC1D22A SETBP1 SVIL ANKRD11 MBD5 VPS13B LARGE1	4.39e-08	192	165	9	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP34 TRIO KDM4C ZHX2 ANKHD1 GAB2 ANKRD11 DENND5A VPS13B	4.59e-08	193	165	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 KDM4C ZHX2 TBC1D22A YAP1 LRP4 ZCCHC7 MBD5 VPS13B	5.24e-08	196	165	9	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	USP34 ANK3 TRIO KDM4C ZHX2 TBC1D22A ZCCHC7 MBD5 VPS13B	5.97e-08	199	165	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	SPEG LAMA2 WFDC1 FRY DST YAP1 SETBP1 COL14A1	5.04e-07	187	165	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BOC ABCA2 ANK3 LZTS3 CCDC85C SF3B3 COBL SORL1	5.04e-07	187	165	8	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO GAB2 FARP2 CD22 SETBP1 ARHGAP25 LY9 LARGE1	5.69e-07	190	165	8	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA6B HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	6.15e-07	192	165	8	bacbaef1f230051335f4433e55db07a161b96b4c
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 OBSCN LAMA2 FRY DST SVIL COBL LARGE1	6.92e-07	195	165	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 ANK3 KDM4C EML4 CDK11A FRYL SEC31B ANKRD11	7.47e-07	197	165	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HSPG2 ERCC4 MMRN2 SHE ARHGAP25 MBD5 VPS13B	3.69e-06	172	165	7	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANK3 OBSCN LAMA2 FRY DST SVIL LARGE1	5.75e-06	184	165	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COPD-Lymphoid-B\|World / Disease state, Lineage and Cell class	USP34 ZHX2 CD22 SETBP1 ARHGAP25 LY9 LARGE1	5.96e-06	185	165	7	22891ed75e25ef30dfa541cb82d85e08ce07e7d9
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	USP34 ZHX2 CD22 SETBP1 ARHGAP25 LY9 LARGE1	5.96e-06	185	165	7	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	KIF13B STARD8 LAMA2 LAMP5 IGDCC4 MMRN2 COL14A1	6.62e-06	188	165	7	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	6.86e-06	189	165	7	12b6f1c3bf526b90e112374bf937701f645c5780
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO MAP2 DST KHDRBS3 SVIL PLAU RIMS2	6.86e-06	189	165	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA6B HSPG2 MAP2 KIAA1549L MMRN2 SHE PKN3	6.86e-06	189	165	7	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO MAP2 DST KHDRBS3 SVIL PLAU RIMS2	6.86e-06	189	165	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	7.10e-06	190	165	7	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IL16 PLEKHF2 CD22 SETBP1 ZCCHC7 LY9 LARGE1	7.10e-06	190	165	7	a7498fe55b7810c482291db782dc5282675d246a
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ANK3 OBSCN LAMA2 DST SVIL RNF207 LARGE1	7.10e-06	190	165	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 MAP2 IRX1 DST PLAU PBXIP1 SORL1	7.60e-06	192	165	7	e19e3e8edcc08e4a67873bfb6e46489ca6c8756a
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC HSPG2 LAMA2 PTGFRN IGSF10 COL14A1 PLAU	7.60e-06	192	165	7	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC HSPG2 LAMA2 PTGFRN IGSF10 COL14A1 PLAU	7.60e-06	192	165	7	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO MAP2 EML4 ZHX2 GAB2 SVIL COBL	7.60e-06	192	165	7	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC HSPG2 LAMA2 PTGFRN IGSF10 COL14A1 PLAU	7.60e-06	192	165	7	ac1477433704573f95111eee6263b93668d2845e
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 MAP2 IRX1 DST PLAU PBXIP1 SORL1	7.60e-06	192	165	7	61c2caf6c838132ed5faa8791c288f2149eba2c8
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 TRH PLXND1 KIAA1549L MMRN2 SHE PKN3	7.60e-06	192	165	7	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 STARD8 MYO7A DCBLD1 PLXND1 MMRN2 SHE	7.86e-06	193	165	7	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	7.86e-06	193	165	7	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	droplet-Fat-Mat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNM DCBLD1 FRY DST MMRN2 SHE PKN3	7.86e-06	193	165	7	54024a373e42e1c0bcc327dc084564b83b63a9d4
ToppCell	droplet-Fat-Mat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNM DCBLD1 FRY DST MMRN2 SHE PKN3	7.86e-06	193	165	7	81d908594d2983ba7e7c1ec25afdde4315d9690e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 FRYL LATS1 DENND1B ZFP69B MED13 VPS13B	7.86e-06	193	165	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	7.86e-06	193	165	7	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 KDM4C EML4 FRYL SEC31B PCSK7 VPS13B	7.86e-06	193	165	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BOC IL16 LAMA2 IGDCC4 IGSF10 SETBP1 COL14A1	7.86e-06	193	165	7	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	7.86e-06	193	165	7	6a623acd1adad9a78eddc32ffedb16352ad3fdfa
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC HSPG2 LAMA2 IGDCC4 IGSF10 KHDRBS3 COL14A1	8.13e-06	194	165	7	5594f7437448cb4b37d2d100f44d30c4a367df26
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA6B HSPG2 MAP2 PLXND1 MMRN2 SHE PKN3	8.41e-06	195	165	7	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	CF-Myeloid\|CF / Disease state, Lineage and Cell class	GAB2 FRY IL1R2 SVIL PLAU DENND5A SORL1	8.41e-06	195	165	7	ecf604de496f389a49429d0bb211e1db6019cc8b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 MAP2 PLXND1 KIAA1549L MMRN2 SHE PKN3	8.41e-06	195	165	7	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA2 WFDC1 LGALS9 IGSF10 TXNDC5 COL14A1	8.69e-06	196	165	7	f47e551ba484687ba6ce8c29a085106131364042
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BOC IL16 LAMA2 IGSF10 DST SETBP1 COL14A1	8.69e-06	196	165	7	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA6B ANKRD65 HSPG2 PLXND1 MMRN2 SHE PLAU	8.69e-06	196	165	7	c5fe470f11ee4962bcfb30cddfd8c078af5b1222
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KIF13B ERBB3 ABCA2 ANK3 SYNM DST COBL	8.98e-06	197	165	7	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA2 WFDC1 PTGFRN IGSF10 TXNDC5 COL14A1	9.28e-06	198	165	7	1b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA6B HSPG2 MAP2 PLXND1 MMRN2 SHE PKN3	9.28e-06	198	165	7	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 TRIO KDM4C GAB2 YAP1 MBD5 VPS13B	9.28e-06	198	165	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA2 WFDC1 PTGFRN IGSF10 TXNDC5 COL14A1	9.28e-06	198	165	7	b086af292a508a156266c2d899ba1caf820bf61c
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BOC LAMP5 PLXND1 PTGFRN COBL CACNA1I	2.66e-05	157	165	6	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	(1)_Control_(PBS)-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	BOC IGDCC4 FARP2 LRP4 COL14A1 SEC23A	2.95e-05	160	165	6	ab769516f9f7798d1390ef215caf22a2d3d53e63
ToppCell	Leuk-UTI-Myeloid-tDC\|Leuk-UTI / Disease, Lineage and Cell Type	ANKRD65 USP11 FARP2 IGSF10 FBH1 GCLC	3.06e-05	161	165	6	51b9f60986ed2e8e2297d31c80462c3ab65a2e5e
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	IL16 LAMA2 GAB3 SHE COL14A1 ARHGAP25	3.75e-05	167	165	6	d2230c894ccf9dbba9196e079ae81f384d43da63
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	B4GALNT1 TRH IGDCC4 FRY SVIL RAB11FIP5	3.88e-05	168	165	6	d02eba7ece17edcdd47fd6b784c93910ce61090f
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRH EML4 IRX1 NUFIP1 GCLC SLC25A53	3.88e-05	168	165	6	ca65321259711321c175ede67bd67a47aad81d7a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FOXM1 MAP2 TOGARAM2 LAMA2 MINAR1 PLK4	4.28e-05	171	165	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B4GALNT1 CD22 CACNA1I LY9 SORL1 CTXN1	4.28e-05	171	165	6	55b194a9bf4d3e4b5d96e0d1298424359c441cbb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FOXM1 MAP2 TOGARAM2 LAMA2 MINAR1 PLK4	4.28e-05	171	165	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B4GALNT1 CD22 CACNA1I LY9 SORL1 CTXN1	4.28e-05	171	165	6	c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXM1 IL16 B4GALNT1 ZNF112 CD22 ARHGAP25	4.57e-05	173	165	6	1cfbab6603f8baf8e238837bb72740c43a7dc0ec
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXM1 IL16 B4GALNT1 ZNF112 CD22 ARHGAP25	4.57e-05	173	165	6	49030c2dd04b592655df1a667e2f90efb499e0a5
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXM1 KIF13B AFF2 KDM4C FRYL LRRC19	4.72e-05	174	165	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA6B HSPG2 PLXND1 MMRN2 SHE PKN3	4.72e-05	174	165	6	42735f6a8e5ec36dd3d35aceea6d37cf3eaa1871
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LYSMD1 PLXND1 C8orf58 SHE PKN3	4.87e-05	175	165	6	98dc3b6f69a29d587f503898f09912700950e3d9
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 WFDC1 PLXND1 MMRN2 FGF5 SHE	5.03e-05	176	165	6	77516048aefbe1f48e825052756df0c310c1c486
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BOC SPEG LAMA2 WFDC1 SETBP1 CNTN3	5.19e-05	177	165	6	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	OBSCN LAMP5 LGALS9 DST SHE PKN3	5.36e-05	178	165	6	0139b42494c1186390b12106dea7957e2b6717c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PLXND1 KIAA1549L MMRN2 SHE PKN3	5.36e-05	178	165	6	5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCell	ILEUM-inflamed-(9)_Neuro_cell\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ERBB3 B4GALNT1 ANK3 DST KHDRBS3 COBL	5.36e-05	178	165	6	611504b0a9e6318b18fba83787b03f9245c82252
ToppCell	ILEUM-inflamed-(9)_Enteric_neurons\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ERBB3 B4GALNT1 ANK3 DST KHDRBS3 COBL	5.36e-05	178	165	6	d9142151819afb0dc22bfb32a9c9dba5f553067d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGDCC4 SVIL PLAU DENND5A RIMS2 LARGE1	5.36e-05	178	165	6	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXN4 SSRP1 IQCC RIMS2 PLK4 CTXN1	5.52e-05	179	165	6	d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXN4 SSRP1 IQCC RIMS2 PLK4 CTXN1	5.52e-05	179	165	6	e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPEG CD300A MMRN2 ARHGAP25 VPS13B SORL1	5.52e-05	179	165	6	db76edd368eeca05a2a5d407c3eb2f535ade0ce3
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SEMA6B HSPG2 PLXND1 LGALS9 MMRN2 SHE	5.52e-05	179	165	6	040a7e916baaf81f44339dc721ab2afcd2c22388
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 MAP2 FRY MMRN2 DENND5A PKN3	5.52e-05	179	165	6	d2db9e70b780643f1e004c41a70464d0abe26088
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HSPG2 TRH PLXND1 LGALS9 MMRN2 SHE	5.70e-05	180	165	6	5861b44acfb8fe92c281c8355bf19c059b3dcd64
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 DCBLD1 ZKSCAN2 PLXND1 MMRN2 SHE	5.88e-05	181	165	6	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	ZHX2 CD22 SETBP1 ARHGAP25 LY9 LARGE1	5.88e-05	181	165	6	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CD22 TBC1D22A SETBP1 ARHGAP25 ZCCHC7 LY9	5.88e-05	181	165	6	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	10x5'-bone_marrow-Mast-Mast_cell_lympho\|bone_marrow / Manually curated celltypes from each tissue	HSPG2 ABCA2 GAB2 FRY COL14A1 SMURF2	5.88e-05	181	165	6	56fa77ae31f3b7de6e441a439c33a11353b6573a
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 ANK3 EML4 ASTL PCSK7 RNF207	5.88e-05	181	165	6	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	facs-Kidney-nan-3m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 TRH PLXND1 DST FBH1 MMRN2	6.06e-05	182	165	6	4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PLXND1 WDR59 IGSF10 ERMAP MMRN2	6.06e-05	182	165	6	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	ANK3 MAP2 LAMA2 YAP1 COBL ROS1	6.24e-05	183	165	6	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	IPF-Lymphoid-B\|IPF / Disease state, Lineage and Cell class	ZHX2 CD22 SETBP1 ARHGAP25 LY9 LARGE1	6.24e-05	183	165	6	e37d2c015c34471a8a54a0299e94b0371e1ada5a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 B4GALNT1 CD22 ARHGAP25 LY9 SORL1	6.24e-05	183	165	6	20f7b6ec2462032eda957a893ca76d5a5a01333d
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	GAB2 IL1R2 SVIL PLAU DENND5A SORL1	6.24e-05	183	165	6	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TXNDC5 CD22 SETBP1 ARHGAP25 ZCCHC7 LY9	6.44e-05	184	165	6	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TXNDC5 CD22 SETBP1 ARHGAP25 ZCCHC7 LY9	6.44e-05	184	165	6	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 WFDC1 PTGFRN IGSF10 COL14A1	6.63e-05	185	165	6	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 WFDC1 PTGFRN IGSF10 COL14A1	6.63e-05	185	165	6	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 WFDC1 PTGFRN IGSF10 COL14A1	6.63e-05	185	165	6	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA6B HSPG2 PLXND1 LGALS9 FRY MMRN2	6.83e-05	186	165	6	055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNM DCBLD1 PLXND1 MMRN2 SLC25A53 SHE	6.83e-05	186	165	6	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYO7A SYNM WFDC1 GCLC LRP4 RNF207	6.83e-05	186	165	6	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 FOXN4 PLXND1 MMRN2 SHE PKN3	6.83e-05	186	165	6	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNM DCBLD1 PLXND1 MMRN2 SLC25A53 SHE	6.83e-05	186	165	6	2cae34336f184f971f7c8684cc27c23a4e7369ed
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	HSPG2 LZTS3 WDR33 CCDC85C WIZ ERMAP PCSK7 RAB11FIP5 RIMS2 HCFC1	1.30e-06	192	163	10	4395_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	HSPG2 ABCA2 TRIO EML4 RRP12 ENTPD5 FGF5 HCFC1 SEC23A SMG6	1.64e-06	197	163	10	4336_DN
Drug	pentasulfane	TRH SYNM WFDC1 CACNA1I	4.31e-06	16	163	4	CID000448216
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	KIF13B B4GALNT1 CCDC85C PLXND1 SF3B3 SETBP1 FGF5 UGGT2 LPAR2	1.23e-05	196	163	9	6309_DN
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A	CYLC1 ABCA2 B4GALNT1 TRH MYO7A WIZ IQCC SNAPC4 PBXIP1	1.29e-05	197	163	9	7052_UP
Drug	0393-0188; Up 200; 10uM; PC3; HT_HG-U133A	CYLC1 HSPG2 ABCA2 TRIO PLXND1 IL1R2 HCFC1 PBXIP1 SMG6	1.29e-05	197	163	9	7510_UP
Drug	NS-398; Up 200; 10uM; PC3; HT_HG-U133A	CYLC1 TRIO MAP2 LAMA2 ENTPD5 FGF5 UGGT2 LPAR2 SEC23A	1.34e-05	198	163	9	6892_UP
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; HL60; HT_HG-U133A	TRIO FARP2 CD22 IL1R2 SVIL PCSK7 GAN PBXIP1 LARGE1	1.34e-05	198	163	9	2175_UP
Drug	(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; HL60; HT_HG-U133A	USP34 TRIO ARHGEF11 WDR59 GAB2 WIZ CD22 IL1R2 MINAR1	1.39e-05	199	163	9	2533_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A	HSPG2 AFF2 TRIO SPEG WDR59 LPAR2 SNAPC4 HCFC1 PBXIP1	1.45e-05	200	163	9	3991_DN
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; HL60; HT_HG-U133A	AFF2 LZTS3 SPEG CCDC85C ARHGEF11 COL14A1 LPAR2 PBXIP1 LARGE1	1.45e-05	200	163	9	3111_UP
Drug	liu	BOC SEMA6B ERBB3 B4GALNT1 MYO7A PRPF6 ATP6V1H GAN CNTN3 SEC13	4.13e-05	285	163	10	CID015991562
Drug	tertiary carboxamide	BOC DST	5.09e-05	2	163	2	CID006419719
Drug	AC1NAX4S	PCSK7 PCSK4	5.09e-05	2	163	2	CID004459028
Drug	Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; MCF7; HT_HG-U133A	USP34 ABCA2 LZTS3 CD22 PLK4 HCFC1 PBXIP1 SEC23A	7.26e-05	191	163	8	5296_UP
Drug	AC1L2VU3	TRH SYNM CACNA1I	7.56e-05	12	163	3	CID000129572
Drug	AC1MIVRO	AFF2 ERMAP CNTN3 ROS1	7.79e-05	32	163	4	CID003080809
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	SPEG PLXND1 ARHGEF11 FARP2 RRP12 ERMAP HCFC1 PBXIP1	8.10e-05	194	163	8	4559_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	TBC1D22A SETBP1 SVIL FGF5 SNAPC4 HCFC1 PBXIP1 SMG6	8.10e-05	194	163	8	6656_DN
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	LZTS3 WDR33 WDR59 LATS1 RRP12 MINAR1 RIMS2 PLK4	8.10e-05	194	163	8	4176_DN
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A	SEMA6B WIZ RRP12 PCSK7 ARHGAP25 LPAR2 LY9 MAN1B1	8.40e-05	195	163	8	1410_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	FARP2 IQCC RRP12 FGF5 CACNA1I PLK4 HCFC1 VPS13B	8.40e-05	195	163	8	3327_UP
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ABCA2 AFF2 CCDC85C ARHGEF11 LATS1 WIZ RIMS2 HCFC1	8.40e-05	195	163	8	4145_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A	USP34 CCDC85C ERMAP PCSK7 COBL FGF5 PLAU SNAPC4	8.40e-05	195	163	8	4495_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	B4GALNT1 WDR33 IL1R2 ERMAP FGF5 COL14A1 SNAPC4 HCFC1	8.70e-05	196	163	8	7269_UP
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	CYLC1 KIF13B USP34 B4GALNT1 PLXND1 ARHGEF11 TBC1D22A HCFC1	8.70e-05	196	163	8	7377_DN
Drug	Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; HL60; HT_HG-U133A	CYLC1 ERBB3 FARP2 WIZ ENTPD5 MINAR1 PLK4 HCFC1	8.70e-05	196	163	8	3055_UP
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; HL60; HT_HG-U133A	CYLC1 USP34 ANK3 WDR33 ZHX2 ERMAP PBXIP1 LARGE1	8.70e-05	196	163	8	1333_UP
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	HSPG2 ABCA2 LZTS3 KDM4C FARP2 TBC1D22A ERMAP DENND5A	9.01e-05	197	163	8	6095_DN
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ABCA2 B4GALNT1 SYNM FRYL TBC1D22A ENTPD5 PCSK7 SNAPC4	9.01e-05	197	163	8	6218_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA	CYLC1 ABCA2 AFF2 ARHGEF11 RRP12 CAPRIN2 VPS13B SMG6	9.01e-05	197	163	8	1013_UP
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; HL60; HT_HG-U133A	CYLC1 LZTS3 ARHGEF11 CD22 RRP12 ERMAP RAB11FIP5 LPAR2	9.01e-05	197	163	8	2150_DN
Drug	valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A	IL16 ABCA2 CCDC85C PLXND1 WIZ IL1R2 FGF5 SNAPC4	9.01e-05	197	163	8	6408_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	CYLC1 B4GALNT1 ANK3 PLXND1 ARHGEF11 WDR59 WIZ UGGT2	9.01e-05	197	163	8	6949_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; HL60; HT_HG-U133A	WDR59 FARP2 IQCC GAN COL14A1 RIMS2 PLK4 PBXIP1	9.01e-05	197	163	8	2404_UP
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; PC3; HT_HG-U133A	WDR33 ARHGEF11 FARP2 TBC1D22A RRP12 FGF5 HCFC1 PBXIP1	9.34e-05	198	163	8	7302_UP
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	KIF13B B4GALNT1 WDR33 CD22 IQCC IL1R2 ENTPD5 LARGE1	9.34e-05	198	163	8	5099_DN
Drug	Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A	ABCA2 SPEG WDR59 SVIL ERMAP SNAPC4 PBXIP1 SEC23A	9.34e-05	198	163	8	4569_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; PC3; HT_HG-U133A	DPYS TRH TBC1D22A RRP12 LRP4 PLK4 PBXIP1 LARGE1	9.34e-05	198	163	8	4189_UP
Drug	Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A	KIF13B USP34 HSPG2 CCDC85C SETBP1 COBL SNAPC4 HCFC1	9.34e-05	198	163	8	7475_UP
Drug	Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A	DPYS LAMA2 CCDC85C WDR59 IL1R2 LRP4 COL14A1 SMG6	9.34e-05	198	163	8	5865_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	HSPG2 ABCA2 KDM4C WDR59 WIZ CD22 PBXIP1 SMG6	9.34e-05	198	163	8	3869_DN
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A	KIF13B LZTS3 LAMA2 TBC1D22A COL14A1 SNAPC4 HCFC1 LARGE1	9.34e-05	198	163	8	5837_UP
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	AFF2 TBC1D22A RRP12 LRP4 FGF5 ROS1 SNAPC4 LY9	9.34e-05	198	163	8	4525_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	ERCC4 MYO7A TBC1D22A RRP12 SVIL LY9 PLK4 HCFC1	9.34e-05	198	163	8	4252_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	STARD8 MAP2 CCDC85C WIZ CACNA1I PLAU SNAPC4 PBXIP1	9.67e-05	199	163	8	4986_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	MYO7A WDR33 CCDC85C LATS1 WIZ SVIL CACNA1I HCFC1	9.67e-05	199	163	8	4562_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	CCDC85C FARP2 WIZ CD22 TBC1D22A FGF5 COL14A1 LY9	9.67e-05	199	163	8	7298_UP
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	CYLC1 B4GALNT1 KDM4C WIZ CAPRIN2 ENTPD5 PLAU VPS13B	9.67e-05	199	163	8	5458_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	KIF13B GAB2 WIZ IL1R2 TBC1D22A SVIL PCSK7 SNAPC4	1.00e-04	200	163	8	1165_DN
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; PC3; HT_HG-U133A	NPY2R WDR33 WIZ TBC1D22A FGF5 MINAR1 HCFC1 LARGE1	1.00e-04	200	163	8	6294_UP
Drug	Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	CYLC1 ABCA2 B4GALNT1 CD22 COBL CACNA1I LPAR2 PLK4	1.00e-04	200	163	8	4505_DN
Drug	TL 401	FOXM1 BOC	1.52e-04	3	163	2	CID000076727
Drug	chloromethyl styrene	BOC CNTN3	1.52e-04	3	163	2	CID000170249
Drug	x C2	ERCC4 SYNM	1.52e-04	3	163	2	CID011705720
Drug	N-(m-aminobenzoyloxy)succinimide	BOC TRH	1.52e-04	3	163	2	CID000125541
Disease	FEV/FEC ratio	BOC USP34 HSPG2 ERBB3 MAP2 WDR33 EML4 SPEG DCBLD1 CCDC85C ZKSCAN2 GAB2 DST SVIL ANKRD11 UGGT2 PLAU DENND5A SMURF2 SMG6 SORL1	2.44e-06	1228	157	21	EFO_0004713
Disease	Neoplasm Metastasis	ERBB3 ERCC4 EML4 GAB2 TXNDC5 YAP1 PLAU MTDH	2.25e-05	217	157	8	C0027627
Disease	unipolar depression, bipolar disorder	ERCC4 ANK3 DENND1B SETBP1 MMRN2 ZCCHC7	1.94e-04	156	157	6	EFO_0003761, MONDO_0004985
Disease	feeling emotionally hurt measurement	ERCC4 DENND1B EXD2 MBD5	2.28e-04	56	157	4	EFO_0009599
Disease	Dwarfism	ERCC4 PLK4 PUS7	3.12e-04	25	157	3	C0013336
Disease	melanoma	ERCC4 MYO7A KDM4C DCBLD1 WFDC1 GAB2 ROS1	3.81e-04	248	157	7	C0025202
Disease	pappalysin-1 measurement	SEMA6B USP34	4.16e-04	6	157	2	EFO_0802845
Disease	dipeptidyl peptidase 2 measurement	ABCA2 MAN1B1	5.80e-04	7	157	2	EFO_0020326
Disease	platelet reactivity measurement, thrombus formation measurement	SETBP1 SVIL	5.80e-04	7	157	2	EFO_0004985, EFO_0007615
Disease	verbal-numerical reasoning measurement	ERBB3 ERCC4 EXD2 RAB11FIP5 CACNA1I	6.95e-04	131	157	5	EFO_0008394
Disease	pneumococcal meningitis	TBC1D22A ROS1	7.71e-04	8	157	2	EFO_1001114
Disease	cleft lip	CCDC168 PTGFRN WDR59 FRY DST TBC1D22A SVIL	8.49e-04	284	157	7	EFO_0003959
Disease	creatinine measurement	DCDC1 TRH USP11 SPEG OBSCN LAMA2 GAB2 FRY SETBP1 SVIL ANKRD11 FGF5 MBD5 SORL1	9.04e-04	995	157	14	EFO_0004518
Disease	gastritis	TCP10L COL14A1	9.88e-04	9	157	2	EFO_0000217
Disease	Nephritis	LGALS9 PLAU	9.88e-04	9	157	2	C0027697
Disease	Paroxysmal atrial fibrillation	USP34 HSPG2 FGF5 MBD5 SORL1	1.51e-03	156	157	5	C0235480
Disease	familial atrial fibrillation	USP34 HSPG2 FGF5 MBD5 SORL1	1.51e-03	156	157	5	C3468561
Disease	Persistent atrial fibrillation	USP34 HSPG2 FGF5 MBD5 SORL1	1.51e-03	156	157	5	C2585653
Disease	Neurodevelopmental Disorders	TRIO TRIP12 SETBP1 ANKRD11	1.56e-03	93	157	4	C1535926
Disease	Atrial Fibrillation	USP34 HSPG2 FGF5 MBD5 SORL1	1.69e-03	160	157	5	C0004238
Disease	Gastric Adenocarcinoma	ERBB3 SPEG ROS1	1.78e-03	45	157	3	C0278701
Disease	Myoinositol measurement	TBC1D22A MTDH	1.79e-03	12	157	2	EFO_0021652
Disease	Congenital muscular dystrophy	LAMA2 LARGE1	1.79e-03	12	157	2	cv:C0699743
Disease	Malignant neoplasm of breast	FOXM1 BOC ERBB3 STARD8 ACO2 OBSCN LAMA2 WFDC1 DDX10 YAP1 SETBP1 MTDH VPS13B SORL1	1.85e-03	1074	157	14	C0006142
Disease	skin and soft tissue Staphylococcus aureus infection	MAP2 GAN	2.11e-03	13	157	2	EFO_1001489
Disease	Leukemia, Myelocytic, Acute	ERCC4 TRH TRIO SETBP1 SVIL	2.38e-03	173	157	5	C0023467
Disease	vital capacity	USP34 HSPG2 TRMT10B MAP2 LAMA2 ZKSCAN2 IRX1 ZHX2 TRIP12 DST CAPRIN2 GAB3 SNAPC4 SMURF2 SMG6	2.55e-03	1236	157	15	EFO_0004312
Disease	monoclonal gammopathy	KHDRBS3 SETBP1 RIMS2	2.85e-03	53	157	3	EFO_0000203
Disease	Neoplasm Invasiveness	GAB2 PLAU RNF207 MTDH SORL1	3.10e-03	184	157	5	C0027626
Disease	cancer (implicated_via_orthology)	ERCC4 SSRP1 TRIP12 LATS1 DST YAP1	3.20e-03	268	157	6	DOID:162 (implicated_via_orthology)
Disease	central nervous system disease (implicated_via_orthology)	ACO2 SEC31B	3.21e-03	16	157	2	DOID:331 (implicated_via_orthology)
Disease	proprotein convertase subtilisin/kexin type 7 measurement	BUD13 PCSK7	3.63e-03	17	157	2	EFO_0008270
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO MED13	3.63e-03	17	157	2	DOID:0060307 (is_implicated_in)
Disease	adverse effect, response to xenobiotic stimulus	ABCA2 COL14A1 LARGE1	3.86e-03	59	157	3	EFO_0009658, GO_0009410
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	SPG11 GAB2 LRP4 PCSK7	4.05e-03	121	157	4	EFO_0008595, EFO_0020943
Disease	sleep duration, high density lipoprotein cholesterol measurement	BUD13 ATP6V1H PCSK7 COBL	4.05e-03	121	157	4	EFO_0004612, EFO_0005271
Disease	glucuronate measurement	PTDSS1 IL1R2	4.07e-03	18	157	2	EFO_0010486
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	BUD13 SPG11 PCSK7	4.24e-03	61	157	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	carcinoma (implicated_via_orthology)	ERBB3 LATS1 YAP1	4.86e-03	64	157	3	DOID:305 (implicated_via_orthology)
Disease	rheumatoid arthritis, COVID-19	ERBB3 ZKSCAN2 FRYL	4.86e-03	64	157	3	EFO_0000685, MONDO_0100096
Disease	bone density	DCDC1 PLXND1 LRP4 RAB11FIP5 COBL ARHGAP25 SMG6	4.88e-03	388	157	7	EFO_0003923

Protein segments in the cluster

Peptide	Gene	Start	Entry
QDSRNASSLPHKGWR	nan	111	A8MWP4
KCTTDHISAAGPWLK	ACO2	591	Q99798
SPDQWRKGKKSTFRH	SMG6	831	Q86US8
HSLNWTKVLRGPTEE	ERBB3	466	P21860
PERASSKTSPHWKES	BUD13	291	Q9BRD0
NKLHPASGADSKDWL	ANKRD11	1666	Q6UB99
VDHASKLKLPWTSRD	B4GALNT1	481	Q00973
WHPQSKTKRVGASEG	BAALC-AS2	6	P0C853
SNRKSKPEWSRDSHN	AFF2	151	P51816
QASPKDSRSLGKDIW	ARHGEF11	351	O15085
LPSSQGHKRDISHWD	C8orf58	286	Q8NAV2
PASSWTDHKEALERG	CTXN1	61	P60606
ESPHGWESPALKKLS	ASTL	341	Q6HA08
HSKRKISWAQPSGLS	IGDCC4	1056	Q8TDY8
SISPGRCKWNKHTLT	MMP26	91	Q9NRE1
HDGAAPISLEWKTRN	HSPG2	3046	P98160
KSSWFGLREAKDPTQ	RAB11FIP5	506	Q9BXF6
PEKAKSHQTWKAGDR	IQCC	61	Q4KMZ1
RIWSKLKNHVSPGAA	NPY2R	241	P49146
SDKHALVTPWLKGDI	LTN1	726	O94822
AIKISKSPDGAHLTW	HCFC1	1896	P51610
SAQRWAIKHEGTSKP	DCDC1	861	M0R2J8
GTSKPGQWKHSRVEN	DCDC1	871	M0R2J8
RDVSDLKVIHWNSPK	LARGE1	371	O95461
GLLEVAKDSIPRSHW	ENTPD5	106	O75356
PQHGEEKKAWTPSRL	LZTS3	651	O60299
VWPHSTERKKQETGA	LYSMD1	116	Q96S90
NSGKELSSHWRPKDV	LPAR2	16	Q9HBW0
QSWKGSKESLVPQRH	LATS1	176	O95835
NDVHRVADSLPGLWK	MMRN2	186	Q9H8L6
NSHRAKWKVISPTGN	DST	916	Q03001
RQEEWSTHSGSKKPE	GAB3	321	Q8WWW8
TRQNGSWGPEERKTH	LGALS9	76	O00182
WDPKGTRTISAKTHH	DPYS	406	Q14117
VVWRKLGDAASSKPS	CCDC85C	391	A6NKD9
SGLDHDVKIWTPTAK	DCAF8L2	531	P0C7V8
SPGEKNDDHSSWRKV	EXD2	266	Q9NVH0
SKPAHLQAEDWRTNG	PCSK4	406	Q6UW60
WPHRSRKAKEEGTEL	PCSK7	706	Q16549
RGISDPDTLHIWKTN	PLXND1	1751	Q9Y4D7
LTSWSRSDGRGDKKH	CWF19L2	416	Q2TBE0
LEEGQKPAHKWIRHS	CYLC1	66	P35663
KRGPLWNHEDVSAKN	FRYL	1761	O94915
KSKLGSWAETGHPDD	GLYATL1	146	Q969I3
QGSPLSWEETKRHAD	GCLC	6	P48506
KRLESSWHGRPTLEK	IL16	476	Q14005
SWHGRPTLEKEREKN	IL16	481	Q14005
AEGENKTSKSWRHPL	KDM4C	561	Q9H3R0
HNMSKGPEATWRLSK	LAMP5	126	Q9UJQ1
HQKPWRAGTFLTKTE	LAMA2	326	P24043
VLRASQHPKKWTADT	KIAA1549L	616	Q6ZVL6
AQVDATGWLRKTPLH	ANKRD65	326	E5RJM6
IHLKATKAGGDSPSW	ALAS2	51	P22557
KFAWGHDELKPVSRS	MAN1B1	266	Q9UKM7
SRAGTPVHWLKDRKA	OBSCN	2851	Q5VST9
DKHPVTWQPSKDGDR	RIMS2	641	Q9UQ26
LSAWAHGEKRLAPKG	FGF5	16	P12034
QPGDHVLIKSWKRES	ZNF561-AS1	76	K7EIQ3
GTSRWDGVSKKAPRH	FBH1	136	Q8NFZ0
HVDWLLADGSKVRAP	IGSF10	506	Q6WRI0
QGNAKPHISWKRESG	IGSF22	91	Q8N9C0
WSKQKHTTDLGFPRS	BOC	881	Q9BWV1
ISHDSIQISWKAPRG	COL14A1	41	Q05707
RVTWHPLSADEGLHK	COL14A1	641	Q05707
EFKRSTGTWHHTKPL	GAN	546	Q9H2C0
WNSLKHKPPSAEHES	CACNA1I	991	Q9P0X4
PLWEKNGSENSHLRT	COBL	456	O75128
KSKLGSWAETGHPDD	GLYATL1B	146	A0A0U1RQE8
DSQSGLHKGQEPWSR	ABCA2	201	Q9BZC7
HITSDLATRGPWDKK	ANK3	2836	Q12955
SDKVKASHWSRSPPR	CDK11A	211	Q9UQ88
DVLSTGPASNKWTKR	DENND5A	676	Q6IQ26
KSWEASGKHQEVSKP	CAPRIN2	421	Q6IMN6
RKPKITWSLRHSEDG	LY9	361	Q9HBG7
EEKWNSVSPASAGKR	MTDH	301	Q86UE4
SAGKRKTEPSAWSQD	MTDH	311	Q86UE4
HTSKKQWDGEQSPRG	MBD5	1191	Q9P267
IAKPGWKNSIRHNLS	FOXM1	276	Q08050
KHRSWHTLTPIADDK	KLHDC1	246	Q8N7A1
WTNSRHKAPSARTAK	KHDRBS3	321	O75525
SIKRPSPAEKSHNSW	EML4	171	Q9HC35
VGPTSHNRKKARWDT	DDX10	836	Q13206
EIHRVWTSASKELPG	FRY	2311	Q5TBA9
AKHSVSIPWEREGSK	CCDC168	2976	Q8NDH2
TEHSPLSKRKEPQWG	CCDC168	4791	Q8NDH2
SGEKALPPWRSSDKH	FBXO16	211	Q8IX29
SGDSSNNHKPREWLE	DCBLD1	301	Q8N8Z6
LALWEGPSKAHTKGS	FARP2	601	O94887
RHSSTFVPWEKEGKE	DENND1B	721	Q6P3S1
QKLGLTEAHKWRPDS	PPP1R18	231	Q6NYC8
LSWKEGKDNHSPVIS	CNTN3	616	Q9P232
RSELKFSPQWSHHGK	CD22	201	P20273
NLTRNSEHEPLGKSW	LRRC19	256	Q9H756
KSGKTPSNEHAAVWV	PLEKHF2	136	Q9H8W4
SSPSEGWLRTKAKHQ	PKN3	306	Q6P5Z2
DTGPGDNKDWHRKSK	MINAR1	751	Q9UPX6
AHSDGAPLWNSRDQK	MROH5	686	Q6ZUA9
RKGKVTASPANGHWL	ERMAP	316	Q96PL5
WTDVRQSSEPSKGAK	GAB2	661	Q9UQC2
SPTGSWQKEAEIHSK	PTGFRN	801	Q9P2B2
KTAPDGWKNSVRHNL	FOXN4	231	Q96NZ1
ADRSHKNPENRKSWA	KIF13B	1811	Q9NQT8
DDASSNTWSPKLLHK	SEC13	246	P55735
HRSKQKNGGDVPTWR	RNF207	616	Q6ZRF8
GFDRSHPNKQLWKSD	SORL1	221	Q92673
LPWIRSHTKEENGLA	PLAU	416	P00749
SGRLEWSPVHKSEKF	ATP6V1H	361	Q9UI12
STGKPKHEWFLQKDS	SVIL	276	O95425
SQAARHIKLGPSEVW	SYNM	1121	O15061
WKARKKSAASPHAGQ	TCP10L	101	Q8TDR4
KLDTPSKGWQARNGH	TOGARAM2	76	Q6ZUX3
KSKWLAGDVPAARSI	PRPF6	616	O94906
HGKPKIWSLAETATS	IRX1	311	P78414
AAGKKALANPRKHSW	PUS7	236	Q96PZ0
NGSPIETLSEWIKHR	WIZ	1431	O95785
SAHPSGKAVVWDLRK	SEC31B	186	Q9NQW1
TRAEAPGKKSWHSQA	SLC25A53	16	Q5H9E4
VKSSCLHPWSKRNDV	MED13	1256	Q9UHV7
GHPDLQKDTSKNAWT	PLK4	506	O00444
NLTWHKNDSARTVPG	IL1R2	66	P27930
DGHPLRLWKASTEVA	STARD8	856	Q92502
KRWKKGHSSDSNPAI	RRP12	16	Q5JTH9
LKTPIRSWHDIDKDN	SEC23A	306	Q15436
LWLNASREKIKSDHP	SSRP1	556	Q08945
AHIDVRNKKGNTPLW	ANKHD1	1316	Q8IWZ3
KWIKAGDHSELSQNP	CD300A	206	Q9UGN4
DWKVNTRLKHCTPDS	SMURF2	636	Q9HAU4
KDHAKTSDPGRSWKI	SPG11	401	Q96JI7
LHAGSAKNIWKRALP	WFDC1	26	Q9HC57
GDRPTLRTVKHDSKW	SEMA6B	211	Q9H3T3
EHALSGWKARTPLEQ	UTP14C	171	Q5TAP6
RSPGKNHKWKNDNSR	NUFIP1	291	Q9UHK0
GSFHSSGEKQKQPRW	PBXIP1	546	Q96AQ6
KQPRWREGTKDSHDP	PBXIP1	556	Q96AQ6
PQVSWHKDGSALRSE	SPEG	751	Q15772
SLLKLQTKDGHRPEW	SPATS1	131	Q496A3
LADKTDHKGELPRGW	RWDD4	156	Q6NW29
VNKTSGPKRGKHAWT	SSX5	151	O60225
KKAPVARSSVGWDAT	ARHGAP25	371	P42331
HKNKTTSWLDPRLDP	YAP1	251	P46937
PLEDSKSHGVKNSPW	TEX13C	911	A0A0J9YWL9
ISWRESHKPNGPKES	ROS1	1576	P08922
HIRADKRVNEWKTPG	SF3B3	526	Q15393
WKRSNSKLPGSIQHV	TBC1D22A	11	Q8WUA7
KDEAKAPHWTSAPLT	MAP2	6	P11137
TSHDGDVRIWDKRKP	WDR59	166	Q6PJI9
EKPRKEHGNGFNWSS	ZNF112	496	Q9UJU3
ATQRLKHGISWSPEE	ZHX2	311	Q9Y6X8
WRETPRKQKQHGKAS	ZNF101	136	Q8IZC7
TEASTWVKLRHPKAA	ZFP69B	11	Q9UJL9
QSDWLSKRQHPGKRE	TRH	76	P20396
QGPSDTKDLHSTKWL	VPS13B	896	Q7Z7G8
ENPHHDIRKGRASWK	ZCCHC7	421	Q8N3Z6
LEQRKEPWTLGLHSS	ZKSCAN2	281	Q63HK3
GHCKTLAPTWEELSK	TXNDC5	351	Q8NBS9
WAKIASELPHRSGSQ	SNAPC4	476	Q5SXM2
DPLWHQLGAKTKSLV	ERCC4	271	Q92889
GIAESHRKRTWPGKS	USP34	1551	Q70CQ2
DHTSKFWTRNRPGDK	WDR33	396	Q9C0J8
AAPGSRDHQKEKSWV	TMEM41B	31	Q5BJD5
ASKSVTAHLAAKWPE	UGGT2	31	Q9NYU1
ETHNWPEALKKGVSS	TRMT10B	291	Q6PF06
WTQKILKPALSDHSE	SHE	366	Q5VZ18
TSPRNAKKHDELWHD	TRIP12	1426	Q14669
HWTQAKEKGDLSSEP	SETBP1	1241	Q9Y6X0
SRKGKLNRSPEHGVW	TRIM50	371	Q86XT4
PEISWHHRKGTKGSE	PTDSS1	426	P48651
TRKKDGTWPSAQLHV	USP11	276	P51784
RPKASITWKGPEHNT	TRIO	2711	O75962
REQPESHTWVKEGKR	GARIN5B	756	Q8N5Q1
GSLPDTGWKHERKLS	LRP4	1886	O75096
KDRLWSHTREPLKQA	MYO7A	1741	Q13402